Search results

  1. F

    Questions for the CureME/UK ME/CFS Biobank team, what do you want to ask? [June 2019 Q&A]

    Ron Davis (OMF) has been looking at red blood cell deformability in ME. However, I don't think they've reached the point where it's a definite yes/no i.e. a diagnostic test for ME or not. It's in one of Ron's video's. I noticed something last night on Health Rising; Cort has an article on ME...
  2. F

    Questions for the CureME/UK ME/CFS Biobank team, what do you want to ask? [June 2019 Q&A]

    At the EMERGE Conference Eliana lacerda (EUROMENE) gave a commitment that the EUROMENE biomarker group will: make recommendations on biomarkers (potential diagnostic tests) in February/March 2020 [10 to 12 minutes]. will advocate (lobby) European MPs (MEPs) i.e. to deliver the EUROMENE...
  3. F

    A new approach to find biomarkers in (CFS/ME) by single-cell Raman micro-spectroscopy, 2018, Morten et al

    A lot has happened since this study was published e.g. the (reversible) fragmentation of mitochondria has been demonstrated (Bhupesh Prusty - NIH Conference last month). On the face of it, this method (RAMAN Spectroscopy) could be assessed against other techniques [SeaHorse, nano-needle...
  4. F

    Dr Karl Morten - UK researcher based at Oxford University

    In short I agree with you strategist - I've just used more words! Morten highlights Fluge and Mella's 2016 publication which as he (Morten) says demonstrates a blockage in the pyruvate dehydrogenase bridge (PDH). He states that the gene expression of PDH is about half of what you would expect...
  5. F

    A nanoelectronics-blood-based diagnostic biomarker for ME/CFS (2019) Esfandyarpour, Davis et al

    Thanks @Trish. Ron Davis, speaking recently, said that when you ask an MS doctor whether (MS) patients have fatigue they say "yes but it's caused by MS not ME". I think Ron went on to say that doctors assume that all of your symptoms are caused by one disease. This supports your view i.e. some...
  6. F

    A nanoelectronics-blood-based diagnostic biomarker for ME/CFS (2019) Esfandyarpour, Davis et al

    I'm with @Simon M here i.e. I'm not much interested in the black box bit; however, I'm very interested in whether it is a diagnostic test. Also, when will we see it delivered here in the UK/EU? ME Action are lobbying for the delivery of a diagnostic test...
  7. F

    A nanoelectronics-blood-based diagnostic biomarker for ME/CFS (2019) Esfandyarpour, Davis et al

    Yea I remember reading a paper; the research (from memory) was done way before the paper was published. I read the conflicts section and yes they had a patent. So it occurred to me that the reason it took so long to publish the paper was that they delayed until they secured the patent.
  8. F

    A nanoelectronics-blood-based diagnostic biomarker for ME/CFS (2019) Esfandyarpour, Davis et al

    If you test samples using the nano-needle and e.g. also: measure Oxygen Consumption [Karl Morten]; and/or measure the surface area/morphology [Bhupesh Prusty]; and/or remove the exosomes (filter plasma/serum) and re-test. Then presumably you can work out whether the nano-needle gives false...
  9. F

    A nanoelectronics-blood-based diagnostic biomarker for ME/CFS (2019) Esfandyarpour, Davis et al

    I wonder if this technology will question current understanding of a range of diseases. I think Ron mentioned that there's fatigue in MS but of course the doctors say that's different. I'm not just thinking Lyme, or Fibro, here. Presumably there are a number of diseases which are mediated(?) by...
  10. F

    A nanoelectronics-blood-based diagnostic biomarker for ME/CFS (2019) Esfandyarpour, Davis et al

    The nano-needle might give "a comparable signal --- in illnesses such as depression and anxiety" wow it might assist in those illnesses (or others) - great. I think the nano-needle might just provide a cascade of diagnostic tests i.e. for ME. Once you have a well defined group of people, with...
  11. F

    A nanoelectronics-blood-based diagnostic biomarker for ME/CFS (2019) Esfandyarpour, Davis et al

    I think we need to be careful about saying that something is non biomedical - after all ME is claimed to be non biomedical. Ron Davis's nano-needle test etc. are forcing some rethinks about ME. Great posts by the way - thanks.
  12. F

    Blog: 'Summary so far of "Something in the blood"' by Simon McGrath

    I think there's enough here [https://mecfsresearchreview.me/2019/04/25/something-in-the-blood/] to justify the funding of a validation study i.e. to develop at least one of these into a diagnostic test. Some of these methods even appear to be based on off the shelf technology e.g. Karl Morten...
  13. F

    Blog: 'Summary so far of "Something in the blood"' by Simon McGrath

    I also got the impression Prusty was saying there were some infected cells. However, I would have assumed Ron Davis's, or Ian Lipkin's [AKA -the great virus hunter - Cort Johnson], teams would have found viral RNA/DNA in the blood - if there were virus's present. Of course, the detection limits...
  14. F

    Blog: 'Summary so far of "Something in the blood"' by Simon McGrath

    I came across this after posting/before reading your replies and yes it refers to something new to me (at least) i.e. prions. From: https://www.frontiersin.org/articles/10.3389/fnins.2017.00026/full "Multiple Sclerosis and Inflammation Inflammation is a central player in most...
  15. F

    Blog: 'Summary so far of "Something in the blood"' by Simon McGrath

    One thing that's slightly bugging me here. A virus (and as Bhupesh Prusty said potentially bacteria) can use mitochondrial fragmentation to evade the immune system. If we don't have a viral infection then why would our cells fragment the mitochondria? Surely if our cells identified a threat...
  16. F

    NIH: Accelerating Research on ME/CFS meeting, 4th and 5th April 2019

    It appears that the thing they've been doing wrong is looking for the right things (microRNA's etc) in the wrong place i.e. blood serum/plasma rather than in the exosomes in the blood serum/plasma. To be fair to NIH, they gave a grant to James Baraniuk in 2015 to look at microRNA's in exosomes...
  17. F

    NIH: Accelerating Research on ME/CFS meeting, 4th and 5th April 2019

    Yes. The first group who identified this were, as Bhupesh Prusty acknowledges earlier in his talk, Fluge/Mella (December 2016). Fluge/Mella used a Seahorse analyser which measures cellular energy metabolism i.e. by measuring "oxygen consumption rate (OCR) and extracellular acidification rate...
  18. F

    NIH: Accelerating Research on ME/CFS meeting, 4th and 5th April 2019

    I hadn't known that i.e. that the PACE trial was funded by a Labour government, or, as @Andy has pointed out, that NICE guidance regarding CBT/GET predated the publication of the PACE trial [Lancet in February 2011...
  19. F

    NIH: Accelerating Research on ME/CFS meeting, 4th and 5th April 2019

    When I looked at one of the slides Ron Davis presented (of Montoya's cytokine study) I thought I don't get this i.e. the results aren't that different for ME Controls/moderately ill/severely ill. Perhaps the P values indicated a significant difference between the controls and those with ME...
Back
Top Bottom